The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone?
Open accessAbstract
Musculoskeletal diseases are highly prevalent with staggering annual health care costs across the globe. The combined wasting of muscle (sarcopenia) and bone (osteoporosis)-both in normal aging and pathologic states-can lead to vastly compounded risk for fracture in patients. Until now, our therapeutic approach to the prevention of such fractures has focused solely on bone, but our increasing understanding of the interconnected biology of muscle and bone has begun to shift our treatment paradigm for musculoskeletal disease. Targeting pathways that centrally regulate both bone and muscle (eg, GH/IGF-1, sex steroids, etc.) and newly emerging pathways that might facilitate communication between these 2 tissues (eg, activin/myostatin) might allow a greater therapeutic benefit and/or previously unanticipated means by which to treat these frail patients and prevent fracture. In this review, we will discuss a number of therapies currently under development that aim to treat musculoskeletal disease in precisely such a holistic fashion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Targeting pathways that centrally regulate both bone and muscle (e.g.growth hormone, IGF-I, sex steroids), and newly emerging pathways that facilitate communications between these two tissues (e.g.activin/myostatin) might allow a greater therapeutic benefit in frail older people [104].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704 · cited 4×
“It also exerts important effects throughout life in glucose and lipid metabolism [29], body composition and bone mineralization [30]. GH is secreted in a pulsatile manner by the pituitary gland and acts by specific growth hormone receptors (GHR) in peripheral tissues, or indirectly through induction of insulin-like gr…”
InfluentialRoss, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,628
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,883
Cited by
Mechanical basis of bone strength: influence of bone material, bone structure and muscle action.
Hart, N. H., Nimphius, S., Rantalainen, T., Ireland, A., Siafarikas, A., & Newton, R. U. (2017) · PubMed Central · Cited by 676
Hofer, H. R., & Tuan, R. S. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0394-0 · Cited by 360
“version of 25-OH-vitamin D3, and controls phosphate reabsorption [136].”
BackgroundOsteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
Greco, E. A., Pietschmann, P., & Migliaccio, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00255 · Cited by 335
A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease
Marty, E., Liu, Y., Samuel, A., Or, O., & Lane, J. (2017) · Bone · doi:10.1016/j.bone.2017.09.008 · Cited by 288
Osteosarcopenia: where osteoporosis and sarcopenia collide
Clynes, M. A., Gregson, C. L., Bruyère, O., Cooper, C., & Dennison, E. M. (2021) · Rheumatology · doi:10.1093/rheumatology/keaa755 · Cited by 268
Metadata
- Authors
- Girgis, C. M., Mokbel, N., & DiGirolamo, D. J.
- Affiliations
- The University of Sydney (AU)
- Garvan Institute of Medical Research (AU)
- Johns Hopkins University (US)
- Corresponding author
- Girgis, Christian M.
- ORCID
- Girgis, Christian M.
- Venue
- Current Osteoporosis Reports
- Published
- 2014-03-16
- Volume
- 12
- Issue
- 2
- Pages
- 142-153
- ISSN
- 1544-1873 (ISSN-L)
- 1544-2241
- PMC
- PMC4083371
- OpenAlex
- W1988354324
- Cited by
- 110
- References
- 133
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 16 · 2021: 10 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 5 · 2015: 8
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Osteoporosis Reports (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Eli Lilly and Company
- Royal Australasian College of Physicians
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR062074)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- musculoskeletal disorders, sarcopenia, osteoporosis, fracture prevention, muscle-bone crosstalk, myostatin, activin, growth hormone/IGF-1 axis, sex steroids, frailty, therapeutic target
- MeSH terms
- Acetamides, Amides, Aminophenols, Androgens, Anilides, Antibodies, Exercise Therapy, Hormones, Humans, Osteoporosis, Growth Hormone-Releasing Hormone, Vitamin D, Human Growth Hormone, Bone Density Conservation Agents, Fractures, Bone, Sarcopenia, Osteoporotic Fractures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone? https://app.cochat.ai/papers/10.1007/s11914-014-0204-5
- The paper
- Girgis, C. M., Mokbel, N., & DiGirolamo, D. J. (2014). Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone? Current Osteoporosis Reports. https://doi.org/10.1007/s11914-014-0204-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.